{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:10:19Z","timestamp":1790187019895,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0019-509x.151984","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:54:03Z","timestamp":1424739243000},"page":"3","source":"Crossref","is-referenced-by-count":3,"title":["Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: A prospective cohort study"],"prefix":"10.4103","volume":"51","author":[{"given":"H","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LW","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JX","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YJ","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JN","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XL","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.151984-1","first-page":"2893","volume-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0019-509X.151984-2","first-page":"1907","volume-title":"Hepatocellular carcinoma","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/0019-509X.151984-3","first-page":"1208","volume-title":"Practice Guidelines Committee, American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"key-10.4103\/0019-509X.151984-4","first-page":"2193","volume-title":"Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer","author":"Nakakuma","year":"1983","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.151984-5","first-page":"1111","volume-title":"Visualization of hepatic lymphatic vessels during transcatheter arterial chemoembolization for hepatocellular carcinoma","author":"Miyayama","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"key-10.4103\/0019-509X.151984-6","first-page":"1734","volume-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/0019-509X.151984-7","first-page":"429","volume-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/0019-509X.151984-8","first-page":"491","volume-title":"Nephrotoxic effects in high-risk patients undergoing angiography","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.151984-9","first-page":"1449","volume-title":"Prevention of nephrotoxicity induced by radiocontrast agents","author":"Barrett","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.151984-10","first-page":"7","volume-title":"Ten-year retrospective analysis of multiple trauma complicated by pulmonary contusion","author":"Jin","year":"2014","journal-title":"Mil Med Res"},{"key":"key-10.4103\/0019-509X.151984-11","first-page":"1419","volume-title":"Contrast-induced acute kidney injury","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0019-509X.151984-12","first-page":"1162","volume-title":"Contrast-induced nephropathy and long-term adverse events: Cause and effect?","author":"Solomon","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0019-509X.151984-13","first-page":"999","volume-title":"Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: A retrospective study of the incidence, risk factors, clinical course and long-term outcome","author":"Huo","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0019-509X.151984-14","first-page":"210","volume-title":"Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A prospective study","author":"Huo","year":"2004","journal-title":"Liver Int"},{"key":"key-10.4103\/0019-509X.151984-15","first-page":"714","volume-title":"Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization","author":"Cho","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"key-10.4103\/0019-509X.151984-16","first-page":"2579","volume-title":"Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma","author":"Zhou","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"key-10.4103\/0019-509X.151984-17","first-page":"1","volume-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/0019-509X.151984-18","first-page":"i12","volume-title":"Contrast medium-induced nephropathy: Critical review of the existing clinical evidence","author":"Bettmann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0019-509X.151984-19","first-page":"930","volume-title":"Hospital-acquired renal insufficiency","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0019-509X.151984-20","first-page":"6","volume-title":"Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: A meta-analysis","author":"Zhou","year":"2014","journal-title":"Mil Med Res"},{"key":"key-10.4103\/0019-509X.151984-21","unstructured":"Speck U. Contrast Media: Overview, Use and Pharmaceutical Aspects. 4 th ed. Berlin, Heidelberg (Germany), New York: Springer; 1999. p. 8-83."},{"key":"key-10.4103\/0019-509X.151984-22","first-page":"i6","volume-title":"Regional alterations in renal haemodynamics and oxygenation: A role in contrast medium-induced nephropathy","author":"Heyman","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0019-509X.151984-23","first-page":"14","volume-title":"Pathophysiology of contrast medium-induced nephropathy","author":"Persson","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/0019-509X.151984-24","first-page":"288","volume-title":"Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy","author":"Heyman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0019-509X.151984-25","first-page":"188","volume-title":"Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy","author":"Heyman","year":"2010","journal-title":"Invest Radiol"},{"key":"key-10.4103\/0019-509X.151984-26","first-page":"149","volume-title":"The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro","author":"Haller","year":"2004","journal-title":"Invest Radiol"},{"key":"key-10.4103\/0019-509X.151984-27","first-page":"e155","volume-title":"In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis","author":"Quintavalle","year":"2011","journal-title":"Cell Death Dis"},{"key":"key-10.4103\/0019-509X.151984-28","first-page":"292","volume-title":"Pathophysiology of renal tissue damage by iodinated contrast media","author":"Sendeski","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key-10.4103\/0019-509X.151984-29","first-page":"811","volume-title":"Contrast-induced nephropathy: Pharmacology, pathophysiology and prevention","author":"Geenen","year":"2013","journal-title":"Insights Imaging"},{"key":"key-10.4103\/0019-509X.151984-30","first-page":"F1592","volume-title":"Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta","author":"Sendeski","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"key-10.4103\/0019-509X.151984-31","first-page":"233","volume-title":"Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/0019-509X.151984-32","first-page":"671","volume-title":"Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis","author":"C\u00e1rdenas","year":"2001","journal-title":"Hepatology"},{"key":"key-10.4103\/0019-509X.151984-33","first-page":"53","volume-title":"Albumin usage in clinical medicine: Tradition or therapeutic?","author":"Farrugia","year":"2010","journal-title":"Transfus Med Rev"},{"key":"key-10.4103\/0019-509X.151984-34","first-page":"599","volume-title":"The role of albumin in critical illness","author":"Nicholson","year":"2000","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0019-509X.151984-35","first-page":"156","volume-title":"Chronic viral hepatitis in kidney transplantation.Nat Rev Nephrol","author":"Huskey","year":"2011","journal-title":""},{"key":"key-10.4103\/0019-509X.151984-36","first-page":"453","volume-title":"Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, non-ionic, monomeric and dimeric agents","author":"Sendeski","year":"2010","journal-title":"Invest Radiol"},{"key":"key-10.4103\/0019-509X.151984-37","first-page":"717","volume-title":"Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro","author":"Duan","year":"2006","journal-title":"J Nephrol"},{"key":"key-10.4103\/0019-509X.151984-38","first-page":"503","volume-title":"The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety","author":"Lenhard","year":"2012","journal-title":"Invest Radiol"},{"key":"key-10.4103\/0019-509X.151984-39","first-page":"175","volume-title":"The effect of iodinated contrast agent properties on renal kinetics and oxygenation","author":"Lenhard","year":"2013","journal-title":"Invest Radiol"},{"key":"key-10.4103\/0019-509X.151984-40","first-page":"2569","volume-title":"Contrast agents and renal cell apoptosis","author":"Romano","year":"2008","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0019-509X.151984-41","doi-asserted-by":"crossref","unstructured":"Laskey W, Aspelin P, Davidson C, Rudnick M, Aubry P, Kumar S, et al. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J 2009;158:822-8.e3.","DOI":"10.1016\/j.ahj.2009.08.016"},{"key":"key-10.4103\/0019-509X.151984-42","first-page":"67","volume-title":"Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial)","author":"Bolognese","year":"2012","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0019-509X.151984-43","first-page":"3189","volume-title":"Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0019-509X.151984-44","first-page":"506479","volume-title":"Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography","author":"Chua","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0019-509X.151984-45","first-page":"368","volume-title":"Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"key":"key-10.4103\/0019-509X.151984-46","first-page":"2259","volume-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/0019-509X.151984-47","doi-asserted-by":"crossref","unstructured":"Valette X, Parienti JJ, Plaud B, Lehoux P, Samba D, Hanouz JL. Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: A prospective cohort study. J Crit Care 2012;27:322.e1-5.","DOI":"10.1016\/j.jcrc.2011.08.005"},{"key":"key-10.4103\/0019-509X.151984-48","first-page":"4","volume-title":"Effect of intra-abdominal volume increment on kidneys in minipigs with intra-abdominal hypertension after hemorrhagic shock and resuscitation","author":"Wang","year":"2014","journal-title":"Mil Med Res"},{"key":"key-10.4103\/0019-509X.151984-49","first-page":"1692","volume-title":"Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database","author":"Joannidis","year":"2009","journal-title":"Intensive Care Med"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:33:43Z","timestamp":1786649623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-509X.151984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"alternative-id":["151984"],"URL":"https:\/\/doi.org\/10.4103\/0019-509x.151984","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}